PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $49 | +2.1% | 46,394 | +48.1% | 0.00% | – |
| Q4 2022 | $48 | -99.9% | 31,328 | -7.9% | 0.00% | -100.0% |
| Q3 2022 | $72,000 | +260.0% | 34,004 | +128.8% | 0.00% | – |
| Q2 2022 | $20,000 | -50.0% | 14,860 | -21.5% | 0.00% | – |
| Q1 2022 | $40,000 | -40.3% | 18,918 | +4.6% | 0.00% | – |
| Q4 2021 | $67,000 | -8.2% | 18,083 | +23.0% | 0.00% | – |
| Q3 2021 | $73,000 | – | 14,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |